TrialClinical pharmacology in drug development2025

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants.

Assem El Baghdady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.